首頁 > 市場調查報告書 > 製藥

DDS

市場調查報告書

商品編碼

1375086

北美藥物輸送市場預測至 2028 年 - COVID-19 影響和區域分析 - 按給藥途徑、配銷通路和最終用戶

North America Drug Delivery Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Route of Administration, Distribution Channel, and End User

出版日期: 2023年08月21日 | 出版商:

The Insight Partners | 英文 233 Pages | 訂單完成後即時交付

價格

簡介目錄圖表

北美給藥市場預計將從2023年的9,746.3953億美元成長到2028年的14,2941,779萬美元。預計2023年至2028年的年複合成長率為8.0%。

慢性病發生率上升推動北美藥物傳輸市場

根據美國疾病管制與預防中心 (CDC) 的數據，截至 2019 年，美國約有十分之六的人患有至少一種慢性病，而約十分之四的人患有兩種或兩種以上慢性病。隨著時間的推移病情惡化，對患者家庭和社會造成巨大負擔。根據美國癌症協會 (ACS) 的預測，到 2023 年，美國可能會新增約 1,958,310 例癌症病例，並有 609,820 人死亡。糖尿病是一種危及生命的慢性疾病，沒有專門的治療方法。所有類型的糖尿病都會導致身體不同部位出現各種併發症，並增加過早死亡的風險。心臟病、中風、腎衰竭、截肢、視力喪失和神經損傷是與這種疾病相關的主要併發症。全球範圍內糖尿病病例顯著增加。

過去幾十年來，慢性病盛行率的增加促進了藥物輸送系統的更深入的研究和開發（R&D）。用於治療慢性疾病的藥物的治療功效可以透過最佳的藥物傳遞系統來提高，例如奈米顆粒（例如陶瓷、聚合物和金屬）、膠束、脂質體和樹枝狀聚合物。透過藥物遞送系統施用藥物還可以幫助減少藥物的全身副作用。已經引入了各種藥物遞送載體，用於針對多種慢性疾病（如糖尿病、癌症、動脈粥樣硬化、心肌缺血、哮喘、肺結核、帕金森氏症和阿茲海默症）進行靶向和受控的治療。適當的藥物傳遞系統可確保藥物長期具有高生物利用度，進而增強任何藥物的治療功效。標靶藥物遞送系統（TDDS）以受控方式在受試者體內預先選定的部位釋放藥物。基於奈米技術的傳輸系統正在對癌症治療產生重大影響，而聚合物在這些奈米顆粒載體的開發中發揮關鍵作用。除了給藥途徑的多功能性之外，奈米治療藥物遞送系統（NDDS）的一些值得注意的技術優勢是延長半衰期、改善生物分佈、增加藥物循環時間、控制和持續藥物釋放以及提高細胞間藥物濃度。

鑑於這些疾病的慢性性質，慢性病患者依賴持續的藥物治療，這與持續的副作用風險有關。開發合適的標靶藥物遞送系統可以促進標靶藥物在致病病灶中的積累，減少全身性副作用，改善患者預後。因此，慢性病和生活方式疾病發生率的增加促進了北美給藥系統市場的成長。

北美藥物輸送市場概況

北美是最大的給藥市場，其中美國佔最大的市場佔有率，其次是加拿大。北美市場成長的特點是生物製藥和生物技術公司對罕見疾病藥物的需求增加、主要市場參與者的存在以及各個學術和研究機構進行的廣泛研發。此外，製藥和生物技術公司的廣泛研究預計將在預測期內支持北美藥物傳輸市場的成長。

北美給藥市場收入及 2028 年預測（百萬美元）

北美給藥市場細分

北美給藥市場根據給藥途徑、配銷通路、最終用戶和國家進行細分。

根據給藥途徑，北美給藥市場分為注射給藥、口服給藥、經黏膜給藥、局部給藥、植入式給藥及眼部給藥。 2023年，注射給藥市場佔據北美給藥市場的最大佔有率。

根據配銷通路，北美給藥市場分為醫院藥房、零售藥房和網路藥房。 2023年，醫院藥局領域佔據北美給藥市場的最大佔有率。

根據最終用戶，北美給藥市場分為醫院和診所、家庭護理機構和其他最終用戶。 2023 年，醫院和診所細分市場在北美給藥市場中佔據最大佔有率。

根據國家/地區，北美給藥市場分為美國、加拿大和墨西哥。 2023年，美國主導北美給藥市佔率。

Bausch Health Companies Inc、Baxter International Inc.、Becton Dickinson and Co、勃林格殷格翰國際有限公司、波士頓科學公司、Gerresheimer AG、葛蘭素史克Plc、強生公司、Kindeva Drug Delivery LP、諾華AG、諾和諾德AS、輝瑞Inc 和Sever Pharma Solutions 是北美藥物輸送市場的領導公司。

市場促進因素
- 慢性病發生率上升
- 對非侵入性給藥系統的需求不斷成長
- 藥廠研發支出增加
主要市場限制
- 與藥物和輸送系統開發相關的高成本
- 藥物輸送系統中的產品召回
主要市場機會
- 專注於提高病患依從性
未來的趨勢
- 策略發展和產品發布
影響分析

第 6 章：藥物輸送市場 - 北美分析

北美給藥市場收入預測與分析

第 7 章：北美藥物輸送市場 - 2028 年收入和預測 - 按給藥途徑

概述
北美藥物輸送市場收入佔有率，依給藥途徑分類（2022 年和 2028 年）
注射給藥
口服給藥
局部給藥
經由黏膜給藥
植入式藥物輸送
眼部藥物輸送

第 8 章：北美藥物輸送市場 - 2028 年收入和預測 - 按配銷通路

概述
北美給藥系統市場收入佔有率，按配銷通路分類（2022 年和 2028 年）
醫院藥房
零售藥局
網路藥局

第 9 章：北美藥物輸送市場 - 2028 年收入和預測 - 按最終用戶

概述
北美給藥系統市場收入佔有率，按最終用戶分類（2022 年和 2028 年）
醫院和診所
家庭護理設置
其他最終用戶

第 10 章：北美藥物輸送市場 - 2028 年收入與預測 - 國家分析

- 美國
- 加拿大
- 墨西哥

第 11 章：北美藥物輸送市場 - 產業格局

概述
北美給藥市場的成長策略
有機成長策略
- 概述
無機成長策略
- 概述

第 12 章：公司簡介

Becton Dickinson and Co
Novo Nordisk AS
Boston Scientific Corp
Baxter International Inc
Gerresheimer AG
Kindeva Drug Delivery LP
GlaxoSmithKline Plc

博士健康公司

主要事實
業務描述
產品與服務
財務概覽
SWOT分析
主要進展

勃林格殷格翰國際股份有限公司

主要事實
業務描述
產品與服務
財務概覽
SWOT分析
主要進展

諾華公司

主要事實
業務描述
產品與服務
財務概覽
SWOT分析
主要進展

塞弗製藥解決方案

主要事實
業務描述
產品與服務
財務概覽
SWOT分析
主要進展

強生公司

主要事實
業務描述
產品與服務
財務概覽
SWOT分析
主要進展

輝瑞公司

主要事實
業務描述
產品與服務
財務概覽
SWOT分析
主要進展

第 13 章：附錄

關於 Insight Partners
專業術語

簡介目錄圖表

Product Code: BMIRE00028761

The North America drug delivery market is expected to grow from US$ 9,74,639.53 million in 2023 to US$ 14,29,417.79 million by 2028. It is estimated to register a CAGR of 8.0% from 2023 to 2028.

Rising Incidence of Chronic Diseases Fuel North America Drug Delivery Market

According to the Centers for Disease Control and Prevention (CDC), ~6 in 10 people in the US suffered from at least one chronic disease, while ~4 in 10 people had two or more chronic diseases as of 2019. Patients suffering from chronic medical conditions deteriorate with time, resulting in an enormous burden on patients' families and society. According to the projections of the American Cancer Society (ACS), the US is likely to record ~1,958,310 new cancer cases and 609,820 deaths in 2023. Diabetes is a life-threatening chronic disease with no specialized cure. All types of diabetes can lead to various complications in different body parts and increase the risk of premature death. Heart attack, stroke, kidney failure, leg amputation, vision loss, and nerve damage are the major complications associated with this disease. Cases of diabetes have been increasing significantly across the globe.

The increased prevalence of chronic diseases has promoted more intensive research and development (R&D) in drug delivery systems in the past few decades. The therapeutic efficacy of drugs used to treat chronic disease can be improved with optimal drug delivery systems, such as nanoparticles (e.g., ceramic, polymeric, and metallic), micelles, liposomes, and dendrimers. Administration of a drug with a drug delivery system can also help reduce systemic side effects of drugs. Various drug delivery vehicles have been introduced for a targeted and controlled delivery of therapeutics against a wide range of chronic diseases, such as diabetes, cancer, atherosclerosis, myocardial ischemia, asthma, pulmonary tuberculosis, Parkinson's, and Alzheimer's. An appropriate drug delivery system enhances the therapeutic efficacy of any drug by ensuring high drug bioavailability for a long duration. Targeted drug delivery systems (TDDS) release drugs in a controlled manner at a preselected site in a subject's body. Nanotechnology-based delivery systems are making a significant impact on cancer treatment, and polymers play a key role in the development of these nanoparticulate carriers. In addition to the versatility of the administration route, a few of the noteworthy technological advantages of nanotherapeutic drug delivery systems (NDDS) are prolonged half-life, improved biodistribution, increased drug circulation time, controlled and sustained drug release, and elevated intercellular drug concentration.

Given the chronic nature of these conditions, patients with chronic diseases rely on continuous drug treatment, which is associated with an ongoing risk of side effects. Developing appropriate delivery systems for targeted drugs can promote the accumulation of targeted medicines in pathogenic lesions, reduce systemic side effects, and improve patient outcomes. Thus, the increasing incidences of chronic and lifestyle diseases bolster the growth of the North America drug delivery systems market.

North America Drug Delivery Market Overview

North America is the largest market for drug delivery, with the US holding the largest market share, followed by Canada. The market growth in North America is characterized by increased demand for rare disease medications from biopharmaceutical and biotechnology companies, the presence of key market players, and extensive R&D conducted by various academic and research institutes. In addition, extensive research in pharmaceutical and biotechnology companies is expected to support the growth of the drug delivery market in North America during the forecast period.

North America Drug Delivery Market Revenue and Forecast to 2028 (US$ Million)

North America Drug Delivery Market Segmentation

The North America drug delivery market is segmented on the basis of route of administration, distribution channel, end user, and country.

Based on route of administration, the North America drug delivery market is segmented into injectable drug delivery, oral drug delivery, transmucosal drug delivery, topical drug delivery, implantable drug delivery, and ocular drug delivery. The injectable drug delivery segment held the largest share of the North America drug delivery market in 2023.

Based on distribution channel, the North America drug delivery market is segmented into hospital pharmacies, retail pharmacies, and online pharmacies. The hospital pharmacies segment held the largest share of the North America drug delivery market in 2023.

Based on end user, the North America drug delivery market is segmented into hospitals and clinics, home care settings, and other end users. The hospitals and clinics segment held the largest share of the North America drug delivery market in 2023.

Based on country, the North America drug delivery market is segmented into the US, Canada, and Mexico. The US dominated the share of the North America drug delivery market in 2023.

Bausch Health Companies Inc, Baxter International Inc., Becton Dickinson and Co, Boehringer Ingelheim International GmbH, Boston Scientific Corp, Gerresheimer AG, GlaxoSmithKline Plc, Johnson & Johnson, Kindeva Drug Delivery LP, Novartis AG, Novo Nordisk AS, Pfizer Inc, and Sever Pharma Solutions are the leading companies operating in the North America drug delivery market.

Reasons to Buy:

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the North America drug delivery market.
Highlights key business priorities in order to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in North America drug delivery market, thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth North America market trends and outlook coupled with the factors driving the market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

1. Introduction

1.1 Study Scope
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
- 1.3.1 North America Drug Delivery Market - by Route of Administration
- 1.3.2 North America Drug Delivery Market - by Distribution Channel
- 1.3.3 North America Drug Delivery Market - by End User
- 1.3.4 North America Drug Delivery Market - by Country

2. North America Drug Delivery Market - Key Takeaways

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. North America Drug Delivery Market - Market Landscape

4.1 Overview
4.2 North America PEST Analysis
4.3 Expert's Opinion

5. North America Drug Delivery Market - Key Market Dynamics

5.1 Market Drivers
- 5.1.1 Rising Incidence of Chronic Diseases
- 5.1.2 Growing Demand for Noninvasive Drug Delivery Systems
- 5.1.3 Increasing R&D Expenditures in Pharmaceutical Companies
5.2 Key Market Restraints
- 5.2.1 High Cost Associated with Development of Drugs and Delivery Systems
- 5.2.2 Product Recalls in Drug Delivery Systems
5.3 Key Market Opportunities
- 5.3.1 Focus on Improving Patient Compliance
5.4 Future Trends
- 5.4.1 Strategic Developments and Product Launches
5.5 Impact analysis

6. Drug Delivery Market - North America Analysis

6.1 North America Drug Delivery Market Revenue Forecast and Analysis

7. North America Drug Delivery Market - Revenue and Forecast to 2028 - By Route of Administration

7.1 Overview
7.2 North America Drug Delivery Market Revenue Share, by Route of Administration (2022 and 2028)
7.3 Injectable Drug Delivery
- 7.3.1 Overview
- 7.3.2 Injectable Drug Delivery: North America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
  - 7.3.2.1 Conventional Injection Devices
    - 7.3.2.1.1 Overview
    - 7.3.2.1.2 Conventional Injection Devices: North America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
  - 7.3.2.2 Advanced Devices
    - 7.3.2.2.1 Overview
    - 7.3.2.2.2 Advanced Devices: North America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
7.4 Oral Drug Delivery
- 7.4.1 Overview
- 7.4.2 Oral Drug Delivery: North America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
  - 7.4.2.1 Solid Oral Drugs
    - 7.4.2.1.1 Overview
    - 7.4.2.1.2 Solid Oral Drugs: North America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
  - 7.4.2.2 Liquid Oral Drugs
    - 7.4.2.2.1 Overview
    - 7.4.2.2.2 Liquid Oral Drugs: North America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
  - 7.4.2.3 Semi-solid Oral Drugs
    - 7.4.2.3.1 Overview
    - 7.4.2.3.2 Semi-solid Oral Drugs: North America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
7.5 Topical Drug Delivery
- 7.5.1 Overview
- 7.5.2 Topical Drug Delivery: North America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
  - 7.5.2.1 Semi-solid Topical Drug Delivery
    - 7.5.2.1.1 Overview
    - 7.5.2.1.2 Semi-solid Topical Drug Delivery: North America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
  - 7.5.2.2 Liquid Topical Drug Delivery Formulations
    - 7.5.2.2.1 Overview
    - 7.5.2.2.2 Liquid Topical Drug Delivery Formulations: North America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
  - 7.5.2.3 Solid Topical Drug Delivery Formulations
    - 7.5.2.3.1 Overview
    - 7.5.2.3.2 Solid Topical Drug Delivery Formulations: North America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
  - 7.5.2.4 Transdermal
    - 7.5.2.4.1 Overview
    - 7.5.2.4.2 Transdermal Patches: North America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
7.6 Transmucosal Drug Delivery
- 7.6.1 Overview
- 7.6.2 Transmucosal Drug Delivery: North America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
  - 7.6.2.1 Pulmonary and Nasal Drug Delivery
    - 7.6.2.1.1 Overview
    - 7.6.2.1.2 Pulmonary and Nasal Drug Delivery: North America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
  - 7.6.2.2 Buccal and Sublingual Drug Delivery
    - 7.6.2.2.1 Overview
    - 7.6.2.2.2 Buccal and Sublingual Drug Delivery: North America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
  - 7.6.2.3 Rectal Transmucosal Drug Delivery
    - 7.6.2.3.1 Overview
    - 7.6.2.3.2 Rectal Transmucosal Drug Delivery: North America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
  - 7.6.2.4 Vaginal Transmucosal Drug Delivery
    - 7.6.2.4.1 Overview
    - 7.6.2.4.2 Vaginal Transmucosal Drug Delivery: North America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
7.7 Implantable Drug Delivery
- 7.7.1 Overview
- 7.7.2 Implantable Drug Delivery: North America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
7.8 Ocular Drug Delivery
- 7.8.1 Overview
- 7.8.2 Ocular Drug Delivery: North America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
  - 7.8.2.1 Eye Drops and Sprays
    - 7.8.2.1.1 Overview
    - 7.8.2.1.2 Eye Drops and Sprays: North America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
  - 7.8.2.2 Gels and Ointments
    - 7.8.2.2.1 Overview
    - 7.8.2.2.2 Gels and Ointments: North America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
  - 7.8.2.3 Ocular Inserts and Punctal Plugs
    - 7.8.2.3.1 Overview
    - 7.8.2.3.2 Ocular Inserts and Punctal Plugs: North America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
  - 7.8.2.4 Therapeutic Contact Lens
    - 7.8.2.4.1 Overview
    - 7.8.2.4.2 Therapeutic Contact Lens: North America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)

8. North America Drug Delivery Market - Revenue and Forecast to 2028 - By Distribution Channel

8.1 Overview
8.2 North America Drug Delivery Systems Market Revenue Share, by Distribution Channel (2022 and 2028)
8.3 Hospital Pharmacies
- 8.3.1 Overview
- 8.3.2 Hospital Pharmacies: North America Drug Delivery Systems Market - Revenue and Forecast to 2028 (US$ Million)
8.4 Retail Pharmacies
- 8.4.1 Overview
- 8.4.2 Retail Pharmacies: North America Drug Delivery Systems Market - Revenue and Forecast to 2028 (US$ Million)
8.5 Online Pharmacies
- 8.5.1 Overview
- 8.5.2 Online Pharmacies: North America Drug Delivery Systems Market - Revenue and Forecast to 2028 (US$ Million)

9. North America Drug Delivery Market - Revenue and Forecast to 2028 - By End User

9.1 Overview
9.2 North America Drug Delivery Systems Market Revenue Share, by End User (2022and 2028)
9.3 Hospitals and Clinics
- 9.3.1 Overview
- 9.3.2 Hospitals and Clinics: North America Drug Delivery Systems Market - Revenue and Forecast to 2028 (US$ Million)
9.4 Home Care Settings
- 9.4.1 Overview
- 9.4.2 Home Care Settings: North America Drug Delivery Systems Market - Revenue and Forecast to 2028 (US$ Million)
9.5 Other End User
- 9.5.1 Overview
- 9.5.2 Other End User: North America Drug Delivery Systems Market - Revenue and Forecast to 2028 (US$ Million)

10. North America Drug Delivery Market - Revenue and Forecast to 2028 - Country Analysis

10.1 Overview
- 10.1.1 North America Drug Delivery Systems Market, by Country, 2022 & 2028 (%)
  - 10.1.1.1 US: North America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.1.1.1 Overview
    - 10.1.1.1.2 US: North America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.1.1.3 US: North America Drug Delivery Market, by Route of Administration, 2020-2028 (US$ Million)
    - 10.1.1.1.3.1 US: North America Drug Delivery Market, by Injectable Drug Delivery, 2020-2028 (US$ Million)
    - 10.1.1.1.3.2 US: North America Drug Delivery Market, by Oral Drug Delivery, 2020-2028 (US$ Million)
    - 10.1.1.1.3.3 US: North America Drug Delivery Market, by Topical Drug Delivery, 2020-2028 (US$ Million)
    - 10.1.1.1.3.4 US: North America Drug Delivery Market, by Transmucosal Drug Delivery, 2020-2028 (US$ Million)
    - 10.1.1.1.3.5 US: North America Drug Delivery Market, by Ocular Drug Delivery, 2020-2028 (US$ Million)
    - 10.1.1.1.4 US: North America Drug Delivery Market, by Distribution Channel, 2020-2028 (US$ Million)
    - 10.1.1.1.5 US: North America Drug Delivery Market, by End User 2020-2028 (US$ Million)
  - 10.1.1.2 Canada: North America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.1.2.1 Overview
    - 10.1.1.2.2 Canada: North America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.1.2.3 Canada: North America Drug Delivery Market, by Route of Administration, 2020-2028 (US$ Million)
    - 10.1.1.2.3.1 Canada: North America Drug Delivery Market, by Injectable Drug Delivery, 2020-2028 (US$ Million)
    - 10.1.1.2.3.2 Canada: North America Drug Delivery Market, by Oral Drug Delivery, 2020-2028 (US$ Million)
    - 10.1.1.2.3.3 Canada: North America Drug Delivery Market, by Topical Drug Delivery, 2020-2028 (US$ Million)
    - 10.1.1.2.3.4 Canada: North America Drug Delivery Market, by Transmucosal Drug Delivery, 2020-2028 (US$ Million)
    - 10.1.1.2.3.5 Canada: North America Drug Delivery Market, by Ocular Drug Delivery, 2020-2028 (US$ Million)
    - 10.1.1.2.4 Canada: North America Drug Delivery Market, by Distribution Channel, 2020-2028 (US$ Million)
    - 10.1.1.2.5 Canada: North America Drug Delivery Market, by End User 2020-2028 (US$ Million)
  - 10.1.1.3 Mexico: North America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.1.3.1 Overview
    - 10.1.1.3.2 Mexico: North America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.1.3.3 Mexico: North America Drug Delivery Market, by Route of Administration, 2020-2028 (US$ Million)
    - 10.1.1.3.3.1 Mexico: North America Drug Delivery Market, by Injectable Drug Delivery, 2020-2028 (US$ Million)
    - 10.1.1.3.3.2 Mexico: North America Drug Delivery Market, by Oral Drug Delivery, 2020-2028 (US$ Million)
    - 10.1.1.3.3.3 Mexico: North America Drug Delivery Market, by Topical Drug Delivery, 2020-2028 (US$ Million)
    - 10.1.1.3.3.4 Mexico: North America Drug Delivery Market, by Transmucosal Drug Delivery, 2020-2028 (US$ Million)
    - 10.1.1.3.3.5 Mexico: North America Drug Delivery Market, by Ocular Drug Delivery, 2020-2028 (US$ Million)
    - 10.1.1.3.4 Mexico: North America Drug Delivery Market, by Distribution Channel, 2020-2028 (US$ Million)
    - 10.1.1.3.5 Mexico: North America Drug Delivery Market, by End User 2020-2028 (US$ Million)

11. North America Drug Delivery Market - Industry Landscape

11.1 Overview
11.2 Growth Strategies in North America Drug Delivery Market
11.3 Organic Growth Strategies
- 11.3.1 Overview
11.4 Inorganic Growth Strategies
- 11.4.1 Overview

12. Company Profiles

12.1 Becton Dickinson and Co
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 Novo Nordisk AS
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 Boston Scientific Corp
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 Baxter International Inc
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 Gerresheimer AG
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 Kindeva Drug Delivery LP
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 GlaxoSmithKline Plc
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
  - 12.7.5.1 Key Developments
12.8 Bausch Health Companies Inc
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
12.9 Boehringer Ingelheim International GmbH
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Products and Services
- 12.9.4 Financial Overview
- 12.9.5 SWOT Analysis
- 12.9.6 Key Developments
12.10 Novartis AG
- 12.10.1 Key Facts
- 12.10.2 Business Description
- 12.10.3 Products and Services
- 12.10.4 Financial Overview
- 12.10.5 SWOT Analysis
- 12.10.6 Key Developments
12.11 Sever Pharma Solutions
- 12.11.1 Key Facts
- 12.11.2 Business Description
- 12.11.3 Products and Services
- 12.11.4 Financial Overview
- 12.11.5 SWOT Analysis
- 12.11.6 Key Developments
12.12 Johnson & Johnson
- 12.12.1 Key Facts
- 12.12.2 Business Description
- 12.12.3 Products and Services
- 12.12.4 Financial Overview
- 12.12.5 SWOT Analysis
- 12.12.6 Key Developments
12.13 Pfizer Inc
- 12.13.1 Key Facts
- 12.13.2 Business Description
- 12.13.3 Products and Services
- 12.13.4 Financial Overview
- 12.13.5 SWOT Analysis
- 12.13.6 Key Developments

13. Appendix

13.1 About The Insight Partners
13.2 Glossary of Terms

簡介目錄圖表

List Of Tables

Table 1. US: North America Drug Delivery Market, by Route of Administration - Revenue and Forecast to 2028 (US$ Million)
Table 2. US: North America Drug Delivery Market, by Injectable Drug Delivery - Revenue and Forecast to 2028 (US$ Million)
Table 3. US: North America Drug Delivery Market, by Oral Drug Delivery - Revenue and Forecast to 2028 (US$ Million)
Table 4. US: North America Drug Delivery Market, by Topical Drug Delivery - Revenue and Forecast to 2028 (US$ Million)
Table 5. US: North America Drug Delivery Market, by Transmucosal Drug Delivery - Revenue and Forecast to 2028 (US$ Million)
Table 6. US: North America Drug Delivery Market, by Ocular Drug Delivery - Revenue and Forecast to 2028 (US$ Million)
Table 7. US: North America Drug Delivery Market, by Distribution Channel- Revenue and Forecast to 2028 (US$ Million)
Table 8. US: North America Drug Delivery Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 9. Canada: North America Drug Delivery Market, by Route of Administration - Revenue and Forecast to 2028 (US$ Million)
Table 10. Canada: North America Drug Delivery Market, by Injectable Drug Delivery - Revenue and Forecast to 2028 (US$ Million)
Table 11. Canada: North America Drug Delivery Market, by Oral Drug Delivery - Revenue and Forecast to 2028 (US$ Million)
Table 12. Canada: North America Drug Delivery Market, by Topical Drug Delivery - Revenue and Forecast to 2028 (US$ Million)
Table 13. Canada: North America Drug Delivery Market, by Transmucosal Drug Delivery - Revenue and Forecast to 2028 (US$ Million)
Table 14. Canada: North America Drug Delivery Market, by Ocular Drug Delivery - Revenue and Forecast to 2028 (US$ Million)
Table 15. Canada: North America Drug Delivery Market, by Distribution Channel- Revenue and Forecast to 2028 (US$ Million)
Table 16. Canada: North America Drug Delivery Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 17. Mexico: North America Drug Delivery Market, by Route of Administration - Revenue and Forecast to 2028 (US$ Million)
Table 18. Mexico: North America Drug Delivery Market, by Injectable Drug Delivery - Revenue and Forecast to 2028 (US$ Million)
Table 19. Mexico: North America Drug Delivery Market, by Oral Drug Delivery - Revenue and Forecast to 2028 (US$ Million)
Table 20. Mexico: North America Drug Delivery Market, by Topical Drug Delivery - Revenue and Forecast to 2028 (US$ Million)
Table 21. Mexico: North America Drug Delivery Market, by Transmucosal Drug Delivery - Revenue and Forecast to 2028 (US$ Million)
Table 22. Mexico: North America Drug Delivery Market, by Ocular Drug Delivery - Revenue and Forecast to 2028 (US$ Million)
Table 23. Mexico: North America Drug Delivery Market, by Distribution Channel- Revenue and Forecast to 2028 (US$ Million)
Table 24. Mexico: North America Drug Delivery Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 25. Recent Organic Growth Strategies in North America Drug Delivery Market
Table 26. Recent Inorganic Growth Strategies in the North America Drug Delivery Market
Table 27. Glossary of Terms, North America Drug delivery market

List Of Figures

Figure 1. North America Drug Delivery Market Segmentation
Figure 2. North America Drug Delivery Market by Country
Figure 3. North America Drug Delivery Market Overview
Figure 4. Injectable Drug Delivery to Hold the Largest Share of Route of Administration Segment in North America Drug Delivery Market
Figure 5. The US Expected to Show Remarkable Growth During Forecast Period
Figure 6. North America: PEST Analysis
Figure 7. Experts' Opinion
Figure 8. North America Drug Delivery Market Impact Analysis of Drivers and Restraints
Figure 9. North America Drug Delivery Market - Revenue Forecast and Analysis - 2020-2028
Figure 10. North America Drug Delivery Market Revenue Share, by Route of Administration (2022 and 2028)
Figure 11. Injectable Drug Delivery: North America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
Figure 12. Conventional Injection Devices: North America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
Figure 13. Advanced Devices: North America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
Figure 14. Oral Drug Delivery: North America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
Figure 15. Solid Oral Drugs: North America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
Figure 16. Liquid Oral Drugs: North America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
Figure 17. Semi-solid Oral Drugs: North America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
Figure 18. Topical Drug Delivery: North America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
Figure 19. Semi-solid Topical Drug Delivery: North America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
Figure 20. Liquid Topical Drug Delivery Formulations: North America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
Figure 21. Solid Topical Drug Delivery Formulations: North America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
Figure 22. Transdermal Patches: North America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
Figure 23. Transmucosal Drug Delivery: North America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
Figure 24. Pulmonary Drug Delivery: North America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
Figure 25. Buccal and Sublingual Drug Delivery: North America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
Figure 26. Rectal Transmucosal Drug Delivery: North America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
Figure 27. Vaginal Transmucosal Drug Delivery: North America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
Figure 28. Implantable Drug Delivery: North America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
Figure 29. Ocular Drug Delivery: North America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
Figure 30. Eye Drops and Sprays: North America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
Figure 31. Gels and Ointments: North America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
Figure 32. Ocular Inserts and Punctal Plugs: North America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
Figure 33. Therapeutic Contact Lens: North America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
Figure 34. North America Drug Delivery Systems Market Revenue Share, by Distribution Channel (2022 and 2028)
Figure 35. Hospital Pharmacies: North America Drug Delivery Systems Market - Revenue and Forecast to 2028 (US$ Million)
Figure 36. Retail Pharmacies: North America Drug Delivery Systems Market - Revenue and Forecast to 2028 (US$ Million)
Figure 37. Online Pharmacies: North America Drug Delivery Systems Market - Revenue and Forecast to 2028 (US$ Million)
Figure 38. North America Drug Delivery Systems Market Revenue Share, by End User (2022 and 2028)
Figure 39. Hospitals and Clinics: North America Drug Delivery Systems Market - Revenue and Forecast to 2028 (US$ Million)
Figure 40. Home Care Settings: North America Drug Delivery Systems Market - Revenue and Forecast to 2028 (US$ Million)
Figure 41. Other End User: North America Drug Delivery Systems Market - Revenue and Forecast to 2028 (US$ Million)
Figure 42. North America Drug Delivery Systems Market, by Key Country - Revenue (2022) (US$ Million)
Figure 43. North America Drug Delivery Systems Market, by Country, 2022 & 2028 (%)
Figure 44. US: North America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
Figure 45. Canada: North America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
Figure 46. Mexico: North America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
Figure 47. Growth Strategies in North America Drug Delivery Market